{
  "attach_pages": "60",
  "attach_size": "4644",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP202003021375739635_1.pdf?1601214928000.pdf",
  "company_code": "80000031",
  "eitime": "2020-03-02 19:29:20",
  "extend": {},
  "info_code": "AP202003021375739635",
  "language": "0",
  "notice_date": "2020-03-02 00:00:00",
  "notice_title": "自研+并购模式巩固医疗器械龙头地位，政策助力公司成长",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "rating": "A",
  "researcher": "全铭",
  "security": [
    {
      "market_uni": "0",
      "publish_relation": [
        {
          "originalCode": "1041",
          "publishName": "医疗器械"
        }
      ],
      "short_name": "迈瑞医疗",
      "short_name_ch": "迈瑞医疗",
      "short_name_cht": "邁瑞醫療",
      "short_name_en": "MR",
      "stock": "300760"
    }
  ],
  "short_name": "迈瑞医疗",
  "source_sample_name": "东吴证券",
  "star": "3"
}